Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4SANOFI-AVENTIS CANADA INC
01 4RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN
01 2KIT
02 2POWDER FOR SOLUTION
01 4ALPROLIX
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN
Brand Name : ALPROLIX
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2422913
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN
Brand Name : ALPROLIX
Dosage Form : KIT
Dosage Strength : 1000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2422921
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN
Brand Name : ALPROLIX
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 2000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2422948
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN
Brand Name : ALPROLIX
Dosage Form : KIT
Dosage Strength : 3000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2422956
Regulatory Info : Schedule D
Registration Country : Canada
